A validated antibody panel for the characterization of tau post-translational modifications.
about
Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tauCharacterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy
P2860
A validated antibody panel for the characterization of tau post-translational modifications.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A validated antibody panel for ...... t-translational modifications.
@en
A validated antibody panel for ...... t-translational modifications.
@nl
type
label
A validated antibody panel for ...... t-translational modifications.
@en
A validated antibody panel for ...... t-translational modifications.
@nl
prefLabel
A validated antibody panel for ...... t-translational modifications.
@en
A validated antibody panel for ...... t-translational modifications.
@nl
P2093
P2860
P1476
A validated antibody panel for ...... t-translational modifications.
@en
P2093
Alexandra Kowalski
Annika Behrendt
Christian Weber
Ebru Ercan
Maria Bichmann
Peter Reinhardt
Simone Fulle
Sybille Krauss
P2860
P2888
P356
10.1186/S13024-017-0229-1
P577
2017-11-21T00:00:00Z
P6179
1092823326